Bpi Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BPI LABS, and what generic alternatives to BPI LABS drugs are available?
BPI LABS has seven approved drugs.
There are three US patents protecting BPI LABS drugs. There is one tentative approval on BPI LABS drugs.
Drugs and US Patents for Bpi Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | 205029-001 | Jul 29, 2014 | AP | RX | Yes | Yes | 10,004,700 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |
Bpi Labs | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 209197-001 | May 8, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | 205029-001 | Jul 29, 2014 | AP | RX | Yes | Yes | 10,039,728 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
Bpi Labs | EPINEPHRINE | epinephrine | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 205029-002 | Feb 4, 2022 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
Bpi Labs | ABLYSINOL | alcohol | SOLUTION;INTRA-ARTERIAL | 207987-002 | Jun 21, 2018 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.